

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.60405451 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.31427766 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.03114373 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.89746301 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.71677620 |
| 6 | glutamate secretion (GO:0014047) | 5.51376169 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.41849174 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.39560688 |
| 9 | vocalization behavior (GO:0071625) | 5.31407258 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.23993026 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.17707900 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.15196184 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.03127626 |
| 14 | protein localization to synapse (GO:0035418) | 4.98075257 |
| 15 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.95012152 |
| 16 | regulation of synapse structural plasticity (GO:0051823) | 4.77631148 |
| 17 | cerebellar granule cell differentiation (GO:0021707) | 4.69985985 |
| 18 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.67515791 |
| 19 | glutamate receptor signaling pathway (GO:0007215) | 4.60326392 |
| 20 | exploration behavior (GO:0035640) | 4.58947076 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.56473205 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.51976469 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 4.51617398 |
| 24 | neuronal action potential propagation (GO:0019227) | 4.51458570 |
| 25 | neurotransmitter secretion (GO:0007269) | 4.43832442 |
| 26 | cellular potassium ion homeostasis (GO:0030007) | 4.38490576 |
| 27 | long-term memory (GO:0007616) | 4.35124224 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.28411993 |
| 29 | amino acid import (GO:0043090) | 4.24474172 |
| 30 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.24048719 |
| 31 | positive regulation of synapse maturation (GO:0090129) | 4.20287101 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 4.19554180 |
| 33 | sodium ion export (GO:0071436) | 4.18003142 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.13465264 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.12043752 |
| 36 | regulation of synaptic plasticity (GO:0048167) | 4.04106222 |
| 37 | positive regulation of membrane potential (GO:0045838) | 4.02738612 |
| 38 | potassium ion homeostasis (GO:0055075) | 3.99433073 |
| 39 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.93543386 |
| 40 | potassium ion import (GO:0010107) | 3.93416817 |
| 41 | layer formation in cerebral cortex (GO:0021819) | 3.92923994 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.88365434 |
| 43 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.84002319 |
| 44 | dendritic spine morphogenesis (GO:0060997) | 3.83060894 |
| 45 | neuron cell-cell adhesion (GO:0007158) | 3.82234006 |
| 46 | proline transport (GO:0015824) | 3.79405072 |
| 47 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.77179393 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.76919496 |
| 49 | long-term synaptic potentiation (GO:0060291) | 3.72438586 |
| 50 | synaptic vesicle endocytosis (GO:0048488) | 3.65805107 |
| 51 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.63747310 |
| 52 | neurotransmitter transport (GO:0006836) | 3.63674407 |
| 53 | activation of protein kinase A activity (GO:0034199) | 3.62015114 |
| 54 | vesicle docking involved in exocytosis (GO:0006904) | 3.61970499 |
| 55 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.61565645 |
| 56 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.60657154 |
| 57 | cell communication by electrical coupling (GO:0010644) | 3.60236357 |
| 58 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.56522438 |
| 59 | neuromuscular process controlling balance (GO:0050885) | 3.54821181 |
| 60 | gamma-aminobutyric acid transport (GO:0015812) | 3.54097539 |
| 61 | transmission of nerve impulse (GO:0019226) | 3.54064999 |
| 62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.53768322 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.53589864 |
| 64 | behavioral fear response (GO:0001662) | 3.49218951 |
| 65 | behavioral defense response (GO:0002209) | 3.49218951 |
| 66 | regulation of exocytosis (GO:0017157) | 3.48031098 |
| 67 | regulation of neurotransmitter secretion (GO:0046928) | 3.46976417 |
| 68 | positive regulation of dendritic spine development (GO:0060999) | 3.45696994 |
| 69 | neuromuscular process controlling posture (GO:0050884) | 3.42940183 |
| 70 | neuron recognition (GO:0008038) | 3.35437263 |
| 71 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.32581166 |
| 72 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.32089012 |
| 73 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31990923 |
| 74 | regulation of neurotransmitter levels (GO:0001505) | 3.31927741 |
| 75 | detection of calcium ion (GO:0005513) | 3.31339709 |
| 76 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.31110537 |
| 77 | membrane depolarization (GO:0051899) | 3.28958213 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.27722081 |
| 79 | regulation of dendritic spine development (GO:0060998) | 3.26105742 |
| 80 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.24949373 |
| 81 | innervation (GO:0060384) | 3.23312703 |
| 82 | positive regulation of neurotransmitter transport (GO:0051590) | 3.23296568 |
| 83 | membrane depolarization during action potential (GO:0086010) | 3.23164734 |
| 84 | dendritic spine organization (GO:0097061) | 3.23010415 |
| 85 | regulation of neurotransmitter transport (GO:0051588) | 3.21948680 |
| 86 | fear response (GO:0042596) | 3.21546225 |
| 87 | regulation of synaptic transmission (GO:0050804) | 3.20789865 |
| 88 | cell differentiation in hindbrain (GO:0021533) | 3.20716500 |
| 89 | long term synaptic depression (GO:0060292) | 3.20393656 |
| 90 | regulation of synapse maturation (GO:0090128) | 3.20346420 |
| 91 | vesicle docking (GO:0048278) | 3.19874432 |
| 92 | cellular sodium ion homeostasis (GO:0006883) | 3.19664773 |
| 93 | axon ensheathment in central nervous system (GO:0032291) | 3.18519344 |
| 94 | central nervous system myelination (GO:0022010) | 3.18519344 |
| 95 | learning (GO:0007612) | 3.17759824 |
| 96 | regulation of ARF protein signal transduction (GO:0032012) | 3.17410647 |
| 97 | postsynaptic membrane organization (GO:0001941) | 3.15976459 |
| 98 | L-amino acid import (GO:0043092) | 3.15870501 |
| 99 | glycine transport (GO:0015816) | 3.15842644 |
| 100 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15152060 |
| 101 | positive regulation of fibroblast migration (GO:0010763) | 3.14596352 |
| 102 | positive regulation of synaptic transmission (GO:0050806) | 3.13656580 |
| 103 | response to histamine (GO:0034776) | 3.10185270 |
| 104 | signal release (GO:0023061) | 3.09662590 |
| 105 | axonal fasciculation (GO:0007413) | 3.09640330 |
| 106 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.09442439 |
| 107 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.07998728 |
| 108 | * synaptic transmission (GO:0007268) | 3.07973202 |
| 109 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.07492258 |
| 110 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.07464313 |
| 111 | prepulse inhibition (GO:0060134) | 3.06711485 |
| 112 | establishment of synaptic vesicle localization (GO:0097480) | 3.06533540 |
| 113 | synaptic vesicle transport (GO:0048489) | 3.06533540 |
| 114 | membrane hyperpolarization (GO:0060081) | 3.05680614 |
| 115 | dendrite morphogenesis (GO:0048813) | 3.04038506 |
| 116 | acidic amino acid transport (GO:0015800) | 3.03015598 |
| 117 | neuronal ion channel clustering (GO:0045161) | 3.00899146 |
| 118 | response to auditory stimulus (GO:0010996) | 3.00364468 |
| 119 | positive regulation of exocytosis (GO:0045921) | 2.98526125 |
| 120 | auditory behavior (GO:0031223) | 2.97642694 |
| 121 | establishment of nucleus localization (GO:0040023) | 2.97427891 |
| 122 | phosphorelay signal transduction system (GO:0000160) | 2.93958755 |
| 123 | neuromuscular process (GO:0050905) | 2.92879190 |
| 124 | neurotransmitter uptake (GO:0001504) | 2.91043034 |
| 125 | cell migration in hindbrain (GO:0021535) | 2.90382103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.44602126 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.24939516 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.21026329 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.20361522 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.19967023 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.97890310 |
| 7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.87598910 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.86121211 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.86121211 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.84402706 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.74677980 |
| 12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.70922884 |
| 13 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.69758549 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.66142734 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.65689017 |
| 16 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.62669508 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53481788 |
| 18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46899161 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.45277002 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.42638540 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.39052777 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.34827180 |
| 23 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27771170 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.23562488 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.18125970 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.15282821 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01651895 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87414282 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69167671 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68266533 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60865271 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58200081 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.51217235 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48935788 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47973881 |
| 36 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.46084881 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.45238227 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44576647 |
| 39 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39721483 |
| 40 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37929493 |
| 41 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.36403028 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34526816 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34234358 |
| 44 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.32622777 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26265270 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.24486747 |
| 47 | AR_19668381_ChIP-Seq_PC3_Human | 1.24317886 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.24056902 |
| 49 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.23578377 |
| 50 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23058423 |
| 51 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22421859 |
| 52 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22209564 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22096390 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21366984 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21308114 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21104398 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20300075 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19568609 |
| 59 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18753350 |
| 60 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18117470 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17714736 |
| 62 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16974568 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16228001 |
| 64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15984275 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14931312 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.14360008 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13626606 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12101182 |
| 69 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.11529865 |
| 70 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11422613 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11213278 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10965031 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09753816 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08946208 |
| 75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08888192 |
| 76 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.05983859 |
| 77 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.05714317 |
| 78 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.05688670 |
| 79 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05446767 |
| 80 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05086669 |
| 81 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.04689445 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03993403 |
| 83 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03404470 |
| 84 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02159862 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00839552 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00479966 |
| 87 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.98188531 |
| 88 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97563999 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97311898 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97234835 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96919912 |
| 92 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.95438515 |
| 93 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.95422096 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94816578 |
| 95 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94641158 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94444913 |
| 97 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94139835 |
| 98 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.93874024 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92937674 |
| 100 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92089549 |
| 101 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91406177 |
| 102 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.91369932 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91010475 |
| 104 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88752653 |
| 105 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.88709450 |
| 106 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88501026 |
| 107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88091824 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88080745 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87903680 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87718595 |
| 111 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87397161 |
| 112 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87007726 |
| 113 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86327649 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84874935 |
| 115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84785082 |
| 116 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84509336 |
| 117 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84062435 |
| 118 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83973456 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83926895 |
| 120 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83380053 |
| 121 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83066364 |
| 122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82171652 |
| 123 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.81894328 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80494201 |
| 125 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.79690595 |
| 126 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.79380681 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79345392 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.77629705 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77575346 |
| 130 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77213002 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.77211116 |
| 132 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77156654 |
| 133 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.77021093 |
| 134 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.74691396 |
| 135 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.74237820 |
| 136 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.73404620 |
| 137 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.72882427 |
| 138 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.72330758 |
| 139 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72192745 |
| 140 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72020980 |
| 141 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.71824040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.74985027 |
| 2 | MP0003880_abnormal_central_pattern | 5.17310755 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.48133738 |
| 4 | MP0009745_abnormal_behavioral_response | 3.62116955 |
| 5 | * MP0002063_abnormal_learning/memory/cond | 3.53593632 |
| 6 | MP0004270_analgesia | 3.46222419 |
| 7 | MP0002064_seizures | 3.31575715 |
| 8 | MP0009046_muscle_twitch | 2.97581699 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.95898319 |
| 10 | MP0002822_catalepsy | 2.95795594 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.85039976 |
| 12 | MP0002272_abnormal_nervous_system | 2.71350448 |
| 13 | MP0001486_abnormal_startle_reflex | 2.60127605 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.51839775 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.50248807 |
| 16 | MP0002736_abnormal_nociception_after | 2.42547664 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.33911410 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.32271366 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.14168853 |
| 20 | MP0008569_lethality_at_weaning | 2.07474051 |
| 21 | MP0002067_abnormal_sensory_capabilities | 1.90648035 |
| 22 | MP0001970_abnormal_pain_threshold | 1.88359714 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.85597024 |
| 24 | MP0004858_abnormal_nervous_system | 1.85312138 |
| 25 | MP0003123_paternal_imprinting | 1.81053682 |
| 26 | MP0004811_abnormal_neuron_physiology | 1.80154318 |
| 27 | MP0003329_amyloid_beta_deposits | 1.77194644 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.73969501 |
| 29 | MP0002184_abnormal_innervation | 1.71230997 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.66800108 |
| 31 | MP0003879_abnormal_hair_cell | 1.65737308 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.60714819 |
| 33 | MP0000955_abnormal_spinal_cord | 1.59356217 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.58087076 |
| 35 | MP0004924_abnormal_behavior | 1.51706451 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.51706451 |
| 37 | MP0000778_abnormal_nervous_system | 1.50724552 |
| 38 | MP0001502_abnormal_circadian_rhythm | 1.47945601 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.43112647 |
| 40 | MP0003787_abnormal_imprinting | 1.42267146 |
| 41 | MP0004885_abnormal_endolymph | 1.39212208 |
| 42 | MP0002066_abnormal_motor_capabilities/c | 1.38873998 |
| 43 | MP0001348_abnormal_lacrimal_gland | 1.35447724 |
| 44 | MP0003633_abnormal_nervous_system | 1.33744832 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.33276969 |
| 46 | MP0003075_altered_response_to | 1.31609193 |
| 47 | MP0004142_abnormal_muscle_tone | 1.30931987 |
| 48 | MP0001984_abnormal_olfaction | 1.30498628 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.22608367 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.10396019 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.10161338 |
| 52 | MP0000751_myopathy | 1.09119573 |
| 53 | MP0003631_nervous_system_phenotype | 1.08750760 |
| 54 | MP0002152_abnormal_brain_morphology | 1.03946990 |
| 55 | MP0001905_abnormal_dopamine_level | 1.03382849 |
| 56 | MP0001177_atelectasis | 1.03089560 |
| 57 | MP0002090_abnormal_vision | 1.02351254 |
| 58 | MP0003122_maternal_imprinting | 1.01347121 |
| 59 | MP0008872_abnormal_physiological_respon | 0.99286391 |
| 60 | MP0002229_neurodegeneration | 0.97541979 |
| 61 | MP0008874_decreased_physiological_sensi | 0.96565368 |
| 62 | MP0002069_abnormal_eating/drinking_beha | 0.94257255 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 0.92522539 |
| 64 | MP0001188_hyperpigmentation | 0.91912192 |
| 65 | MP0010386_abnormal_urinary_bladder | 0.91006457 |
| 66 | MP0003283_abnormal_digestive_organ | 0.90643511 |
| 67 | MP0001529_abnormal_vocalization | 0.90473369 |
| 68 | MP0003121_genomic_imprinting | 0.88758379 |
| 69 | MP0008961_abnormal_basal_metabolism | 0.87461220 |
| 70 | MP0004510_myositis | 0.85917146 |
| 71 | MP0004085_abnormal_heartbeat | 0.85739605 |
| 72 | MP0002234_abnormal_pharynx_morphology | 0.84324429 |
| 73 | MP0005535_abnormal_body_temperature | 0.81078045 |
| 74 | MP0003690_abnormal_glial_cell | 0.80491288 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.79931349 |
| 76 | MP0000013_abnormal_adipose_tissue | 0.77350068 |
| 77 | MP0001963_abnormal_hearing_physiology | 0.75635523 |
| 78 | MP0003045_fibrosis | 0.75573865 |
| 79 | MP0004130_abnormal_muscle_cell | 0.75504280 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 0.74605325 |
| 81 | MP0003634_abnormal_glial_cell | 0.74588193 |
| 82 | MP0006292_abnormal_olfactory_placode | 0.73953744 |
| 83 | MP0002752_abnormal_somatic_nervous | 0.73891160 |
| 84 | MP0001664_abnormal_digestion | 0.73343076 |
| 85 | MP0000604_amyloidosis | 0.71830482 |
| 86 | MP0004233_abnormal_muscle_weight | 0.70561635 |
| 87 | MP0004147_increased_porphyrin_level | 0.68976186 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.68909899 |
| 89 | MP0003632_abnormal_nervous_system | 0.68136614 |
| 90 | MP0008877_abnormal_DNA_methylation | 0.67113802 |
| 91 | MP0004742_abnormal_vestibular_system | 0.65585003 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.65537663 |
| 93 | MP0000920_abnormal_myelination | 0.64932412 |
| 94 | MP0006072_abnormal_retinal_apoptosis | 0.64641429 |
| 95 | MP0000631_abnormal_neuroendocrine_gland | 0.64264874 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.63878901 |
| 97 | MP0005499_abnormal_olfactory_system | 0.63878901 |
| 98 | MP0005409_darkened_coat_color | 0.63337062 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.61886815 |
| 100 | MP0004484_altered_response_of | 0.61063124 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.60732259 |
| 102 | MP0008260_abnormal_autophagy | 0.60641955 |
| 103 | MP0001485_abnormal_pinna_reflex | 0.59966453 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.58783167 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.55845725 |
| 106 | MP0005166_decreased_susceptibility_to | 0.55654939 |
| 107 | MP0010769_abnormal_survival | 0.52821007 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.52063932 |
| 109 | MP0003172_abnormal_lysosome_physiology | 0.51209688 |
| 110 | MP0001943_abnormal_respiration | 0.51136414 |
| 111 | MP0000747_muscle_weakness | 0.50646304 |
| 112 | MP0003956_abnormal_body_size | 0.49874253 |
| 113 | MP0003303_peritoneal_inflammation | 0.46750955 |
| 114 | MP0000681_abnormal_thyroid_gland | 0.45959382 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.45172211 |
| 116 | MP0010768_mortality/aging | 0.44716247 |
| 117 | MP0002083_premature_death | 0.44307875 |
| 118 | MP0000639_abnormal_adrenal_gland | 0.44191943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.10085225 |
| 2 | Myokymia (HP:0002411) | 7.84215539 |
| 3 | Focal seizures (HP:0007359) | 5.98922401 |
| 4 | Visual hallucinations (HP:0002367) | 5.69013602 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.97910625 |
| 6 | Febrile seizures (HP:0002373) | 4.86155326 |
| 7 | Atonic seizures (HP:0010819) | 4.84507124 |
| 8 | Absence seizures (HP:0002121) | 4.53557388 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.45165839 |
| 10 | Dialeptic seizures (HP:0011146) | 4.16423651 |
| 11 | Action tremor (HP:0002345) | 4.07514989 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.04648855 |
| 13 | Abnormality of the lower motor neuron (HP:0002366) | 3.88108797 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.86746799 |
| 15 | Obstructive sleep apnea (HP:0002870) | 3.83709178 |
| 16 | Depression (HP:0000716) | 3.57121085 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.47542787 |
| 18 | Ankle clonus (HP:0011448) | 3.45705823 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.43088537 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 3.31420588 |
| 21 | Poor eye contact (HP:0000817) | 3.30893156 |
| 22 | Dysmetria (HP:0001310) | 3.28957389 |
| 23 | Tetraplegia (HP:0002445) | 3.26346957 |
| 24 | Postural instability (HP:0002172) | 3.26149751 |
| 25 | Broad-based gait (HP:0002136) | 3.17963450 |
| 26 | Ventricular fibrillation (HP:0001663) | 3.16090587 |
| 27 | Cerebral hypomyelination (HP:0006808) | 3.13013049 |
| 28 | Impaired smooth pursuit (HP:0007772) | 3.10757765 |
| 29 | Anxiety (HP:0000739) | 3.10698139 |
| 30 | Truncal ataxia (HP:0002078) | 3.07843928 |
| 31 | Akinesia (HP:0002304) | 2.99556789 |
| 32 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.97337992 |
| 33 | Mutism (HP:0002300) | 2.97216345 |
| 34 | Abnormal social behavior (HP:0012433) | 2.96904363 |
| 35 | Impaired social interactions (HP:0000735) | 2.96904363 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.93399088 |
| 37 | Amblyopia (HP:0000646) | 2.89321269 |
| 38 | Annular pancreas (HP:0001734) | 2.82861405 |
| 39 | Papilledema (HP:0001085) | 2.81418461 |
| 40 | Scanning speech (HP:0002168) | 2.79109160 |
| 41 | Hemiplegia (HP:0002301) | 2.74770759 |
| 42 | Torticollis (HP:0000473) | 2.74094508 |
| 43 | Apathy (HP:0000741) | 2.72548197 |
| 44 | Hemiparesis (HP:0001269) | 2.69415337 |
| 45 | Genetic anticipation (HP:0003743) | 2.69380487 |
| 46 | Urinary urgency (HP:0000012) | 2.65320788 |
| 47 | Stereotypic behavior (HP:0000733) | 2.63923944 |
| 48 | Bradykinesia (HP:0002067) | 2.63754043 |
| 49 | Sleep apnea (HP:0010535) | 2.62688422 |
| 50 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.62470357 |
| 51 | Limb dystonia (HP:0002451) | 2.61002474 |
| 52 | Status epilepticus (HP:0002133) | 2.59440466 |
| 53 | Polyphagia (HP:0002591) | 2.54796068 |
| 54 | Hyperventilation (HP:0002883) | 2.54603550 |
| 55 | Pointed chin (HP:0000307) | 2.54257201 |
| 56 | Focal dystonia (HP:0004373) | 2.52786677 |
| 57 | Diminished motivation (HP:0000745) | 2.49299964 |
| 58 | Intention tremor (HP:0002080) | 2.48930975 |
| 59 | Spastic gait (HP:0002064) | 2.44938553 |
| 60 | Dysmetric saccades (HP:0000641) | 2.42883640 |
| 61 | Drooling (HP:0002307) | 2.34862050 |
| 62 | Excessive salivation (HP:0003781) | 2.34862050 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.31175051 |
| 64 | Insomnia (HP:0100785) | 2.30555624 |
| 65 | Spastic tetraparesis (HP:0001285) | 2.30356142 |
| 66 | Impaired vibratory sensation (HP:0002495) | 2.30004498 |
| 67 | Abnormality of binocular vision (HP:0011514) | 2.26699783 |
| 68 | Diplopia (HP:0000651) | 2.26699783 |
| 69 | Generalized myoclonic seizures (HP:0002123) | 2.20846404 |
| 70 | Peripheral hypomyelination (HP:0007182) | 2.20523761 |
| 71 | Craniofacial dystonia (HP:0012179) | 2.17660725 |
| 72 | Ankyloglossia (HP:0010296) | 2.17314468 |
| 73 | Fetal akinesia sequence (HP:0001989) | 2.16822320 |
| 74 | Iris hypopigmentation (HP:0007730) | 2.16591639 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 2.15690396 |
| 76 | Choreoathetosis (HP:0001266) | 2.15676465 |
| 77 | Progressive inability to walk (HP:0002505) | 2.14426800 |
| 78 | Incomplete penetrance (HP:0003829) | 2.12029957 |
| 79 | Megalencephaly (HP:0001355) | 2.11936670 |
| 80 | EEG with generalized epileptiform discharges (HP:0011198) | 2.11361107 |
| 81 | Slow saccadic eye movements (HP:0000514) | 2.09214312 |
| 82 | Neurofibrillary tangles (HP:0002185) | 2.07514413 |
| 83 | Abnormality of the corticospinal tract (HP:0002492) | 2.04732782 |
| 84 | Ocular albinism (HP:0001107) | 2.04293063 |
| 85 | Memory impairment (HP:0002354) | 2.04021977 |
| 86 | Abnormal EKG (HP:0003115) | 2.02816077 |
| 87 | Lower limb muscle weakness (HP:0007340) | 2.02249310 |
| 88 | Rapidly progressive (HP:0003678) | 2.01394381 |
| 89 | Global brain atrophy (HP:0002283) | 2.00433387 |
| 90 | Retinal dysplasia (HP:0007973) | 2.00249256 |
| 91 | Bundle branch block (HP:0011710) | 1.99149927 |
| 92 | Absent speech (HP:0001344) | 1.98801257 |
| 93 | CNS hypomyelination (HP:0003429) | 1.98616229 |
| 94 | Delusions (HP:0000746) | 1.97731344 |
| 95 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.97259235 |
| 96 | Spinal canal stenosis (HP:0003416) | 1.96552196 |
| 97 | Abnormality of saccadic eye movements (HP:0000570) | 1.96154755 |
| 98 | Increased circulating renin level (HP:0000848) | 1.95117363 |
| 99 | Hypsarrhythmia (HP:0002521) | 1.93443693 |
| 100 | Rigidity (HP:0002063) | 1.91951233 |
| 101 | Dementia (HP:0000726) | 1.90031088 |
| 102 | Gait ataxia (HP:0002066) | 1.87703814 |
| 103 | Central scotoma (HP:0000603) | 1.86982702 |
| 104 | Abnormality of the periventricular white matter (HP:0002518) | 1.86149567 |
| 105 | Clonus (HP:0002169) | 1.85284938 |
| 106 | Resting tremor (HP:0002322) | 1.84279623 |
| 107 | Limb ataxia (HP:0002070) | 1.83923009 |
| 108 | Failure to thrive in infancy (HP:0001531) | 1.83138936 |
| 109 | Lower limb amyotrophy (HP:0007210) | 1.82139753 |
| 110 | Anosmia (HP:0000458) | 1.80673971 |
| 111 | Lower limb asymmetry (HP:0100559) | 1.78807296 |
| 112 | Hypoventilation (HP:0002791) | 1.78635996 |
| 113 | Congenital stationary night blindness (HP:0007642) | 1.78456142 |
| 114 | Inability to walk (HP:0002540) | 1.77208203 |
| 115 | Type II lissencephaly (HP:0007260) | 1.76674886 |
| 116 | Deep palmar crease (HP:0006191) | 1.75148059 |
| 117 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74392339 |
| 118 | Neuronal loss in central nervous system (HP:0002529) | 1.74226924 |
| 119 | Psychosis (HP:0000709) | 1.73078330 |
| 120 | Protruding tongue (HP:0010808) | 1.70315168 |
| 121 | Insidious onset (HP:0003587) | 1.70309186 |
| 122 | Termporal pattern (HP:0011008) | 1.70309186 |
| 123 | Neoplasm of the heart (HP:0100544) | 1.70294372 |
| 124 | Thickened helices (HP:0000391) | 1.66012269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.50532373 |
| 2 | NTRK3 | 4.96912056 |
| 3 | MAP3K9 | 4.08902922 |
| 4 | MINK1 | 2.72144052 |
| 5 | KSR2 | 2.56199178 |
| 6 | DAPK2 | 2.52850317 |
| 7 | MAP3K4 | 2.50739368 |
| 8 | PRKD3 | 2.29934333 |
| 9 | PAK6 | 2.25028903 |
| 10 | MAP3K13 | 2.06426455 |
| 11 | CAMKK1 | 2.00490281 |
| 12 | MAP2K7 | 1.99372842 |
| 13 | RIPK4 | 1.98977420 |
| 14 | MARK1 | 1.96700608 |
| 15 | NTRK2 | 1.94936010 |
| 16 | PRPF4B | 1.94366296 |
| 17 | ARAF | 1.92900425 |
| 18 | TNIK | 1.87629563 |
| 19 | KSR1 | 1.70498186 |
| 20 | DAPK1 | 1.67794769 |
| 21 | FES | 1.58500769 |
| 22 | MAP3K12 | 1.58252120 |
| 23 | STK38 | 1.55808538 |
| 24 | MAP2K4 | 1.55745895 |
| 25 | CDK5 | 1.54929234 |
| 26 | NTRK1 | 1.48568925 |
| 27 | CDK19 | 1.44715889 |
| 28 | CASK | 1.43231046 |
| 29 | GRK5 | 1.26859009 |
| 30 | MAP3K2 | 1.21734012 |
| 31 | SIK2 | 1.19138963 |
| 32 | PLK2 | 1.18571435 |
| 33 | PRKCG | 1.15927152 |
| 34 | PINK1 | 1.09218539 |
| 35 | RAF1 | 1.08517350 |
| 36 | MAP3K11 | 1.07509245 |
| 37 | MAPK13 | 1.07226381 |
| 38 | MAP3K7 | 1.04590387 |
| 39 | TAOK1 | 1.04358226 |
| 40 | PTK2B | 1.03030059 |
| 41 | CAMKK2 | 1.01235453 |
| 42 | MARK2 | 0.99256907 |
| 43 | TYRO3 | 0.98889763 |
| 44 | UHMK1 | 0.96870221 |
| 45 | LMTK2 | 0.95449483 |
| 46 | * CAMK1 | 0.94619088 |
| 47 | CAMK2A | 0.94003866 |
| 48 | PRKCH | 0.91788100 |
| 49 | TNK2 | 0.91324458 |
| 50 | CAMK2B | 0.86084004 |
| 51 | CDK18 | 0.83736389 |
| 52 | CDK15 | 0.83115239 |
| 53 | MAP3K1 | 0.80939163 |
| 54 | PDK1 | 0.80401235 |
| 55 | NME1 | 0.79909650 |
| 56 | MAP2K6 | 0.79694655 |
| 57 | STK11 | 0.77658566 |
| 58 | CDK14 | 0.77368195 |
| 59 | RET | 0.77190235 |
| 60 | ALK | 0.74218138 |
| 61 | SGK223 | 0.73973110 |
| 62 | SGK494 | 0.73973110 |
| 63 | CDK11A | 0.73682283 |
| 64 | PHKG1 | 0.72581570 |
| 65 | PHKG2 | 0.72581570 |
| 66 | WNK1 | 0.69607600 |
| 67 | CAMK1D | 0.68013904 |
| 68 | PDPK1 | 0.66908774 |
| 69 | DYRK1A | 0.66679363 |
| 70 | TAOK2 | 0.65807626 |
| 71 | TRIB3 | 0.65134725 |
| 72 | RIPK1 | 0.64674345 |
| 73 | IRAK2 | 0.61968663 |
| 74 | PNCK | 0.61853860 |
| 75 | SGK1 | 0.60325994 |
| 76 | PRKG2 | 0.56866480 |
| 77 | FER | 0.56750173 |
| 78 | BMPR2 | 0.56098103 |
| 79 | SGK3 | 0.53714053 |
| 80 | MOS | 0.53008237 |
| 81 | SGK2 | 0.52839688 |
| 82 | BRSK1 | 0.52616937 |
| 83 | PRKD2 | 0.52140755 |
| 84 | CAMK4 | 0.51849581 |
| 85 | NEK1 | 0.50940082 |
| 86 | LATS2 | 0.50503852 |
| 87 | PAK3 | 0.50401788 |
| 88 | JAK2 | 0.49592447 |
| 89 | DMPK | 0.48644032 |
| 90 | RPS6KA3 | 0.47368822 |
| 91 | CAMK2D | 0.47357371 |
| 92 | BRAF | 0.46830191 |
| 93 | CAMK2G | 0.45195619 |
| 94 | MAP2K1 | 0.44630404 |
| 95 | MAPK10 | 0.43342717 |
| 96 | MUSK | 0.42189409 |
| 97 | NEK6 | 0.42137763 |
| 98 | FYN | 0.41807492 |
| 99 | CDC42BPA | 0.40931663 |
| 100 | PKN1 | 0.40156570 |
| 101 | EEF2K | 0.38106559 |
| 102 | DAPK3 | 0.37983369 |
| 103 | PRKCZ | 0.37625325 |
| 104 | CSNK1G2 | 0.37324871 |
| 105 | OXSR1 | 0.34606204 |
| 106 | PRKCE | 0.34314081 |
| 107 | RPS6KA2 | 0.33781139 |
| 108 | FGFR2 | 0.31295596 |
| 109 | HIPK2 | 0.31095539 |
| 110 | MAPK12 | 0.30961370 |
| 111 | MAPK8 | 0.30676186 |
| 112 | FGR | 0.30216993 |
| 113 | ROCK2 | 0.29528661 |
| 114 | CAMK1G | 0.29407379 |
| 115 | PRKCA | 0.29039904 |
| 116 | PRKAA1 | 0.25885502 |
| 117 | ERBB2 | 0.25872691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.73222395 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.29883263 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.92960908 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.86134541 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.75947179 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.68138285 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66583696 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.66386118 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.54652611 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.52673109 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.29544238 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.28969809 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10704577 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.04417295 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.98402393 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.95185066 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.95162878 |
| 18 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.76038813 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.73930149 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70615830 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.64840923 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.64491314 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.62009586 |
| 24 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.58093688 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55700238 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.55014051 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52448841 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.47497694 |
| 29 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.37836994 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.36857046 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34799824 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.30548343 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.26597249 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24973398 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22378167 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20024948 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.16152396 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15566963 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09851367 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07281570 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06442254 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.03936588 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01709736 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.01290101 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99774822 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98820544 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96857224 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96708218 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94200857 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92002985 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.89518721 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.86867412 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85953246 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82724854 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80424107 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80069928 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77544541 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76653081 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73053935 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72125534 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70719098 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69928668 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67782375 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66260749 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63942421 |
| 66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63025227 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62594450 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60088562 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60013620 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59997288 |
| 71 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56480397 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55287637 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.53128238 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51444845 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49244447 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48899058 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44905047 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44749826 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44516538 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43746517 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.43741492 |
| 82 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43681030 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42049681 |
| 84 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41250314 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39903031 |
| 86 | * Alcoholism_Homo sapiens_hsa05034 | 0.39234150 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39067487 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.38207393 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36993087 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.36000161 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35189620 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34267138 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34037799 |
| 94 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33868701 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33775578 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33729605 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33691049 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.33081362 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.33031278 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32506314 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.32363698 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32275042 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32073828 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31737680 |
| 105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30614000 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28625039 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28498543 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27940341 |
| 109 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27718905 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26585233 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.25685449 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24412833 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24156359 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22922647 |

